PAPER Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K
SEARCH RESULTS
331386 RESULTS
PAPER Fox LM, William CM, Adamowicz DH, Pitstick R, Carlson GA, Spires-Jones TL, Hyman BT
Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
J Neuropathol Exp Neurol. 2011 Jul;70(7):588-95. PubMed: 21666499PAPER Stone JG, Siedlak SL, Tabaton M, Hirano A, Castellani RJ, Santocanale C, Perry G, Smith MA, Zhu X, Lee HG
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.
J Neuropathol Exp Neurol. 2011 Jul;70(7):578-87. PubMed: 21666500PAPER Inayathullah M, Teplow DB
Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein.
Amyloid. 2011 Sep;18(3):98-107. Epub 2011 Jun 13 PubMed: 21668291PAPER Sun KH, Chang KH, Clawson S, Ghosh S, Mirzaei H, Regnier F, Shah K
Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.
J Neurochem. 2011 Sep;118(5):902-14. PubMed: 21668448PAPER Melis RJ, Angleman SB, Fratiglioni L
Development and validation of a composite score as an easy-to-use instrument for clinical monitoring of dementia progression: the Composite Cognitive and Activities of Daily Living Functioning Score.
J Am Geriatr Soc. 2011 Jun;59(6):1154-5. PubMed: 21668928PAPER Rosenberg RN
Treat Alzheimer disease before it is symptomatic.
Arch Neurol. 2011 Oct;68(10):1237-8. PubMed: 21670383PAPER Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ,
Longitudinal change of biomarkers in cognitive decline.
Arch Neurol. 2011 Oct;68(10):1257-66. PubMed: 21670386PAPER Bayer-Carter JL, Green PS, Montine TJ, Vanfossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, Lampe J, Kahn SE, Craft S
Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.
Arch Neurol. 2011 Jun;68(6):743-52. PubMed: 21670398PAPER Nelson LD, Siddarth P, Kepe V, Scheibel KE, Huang SC, Barrio JR, Small GW
Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome.
Arch Neurol. 2011 Jun;68(6):768-74. PubMed: 21670401PAPER Hachinski V
Stroke and Alzheimer disease: fellow travelers or partners in crime?
Arch Neurol. 2011 Jun;68(6):797-8. PubMed: 21670403PAPER Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8485-90. PubMed: 21525407PAPER Attwood BK, Bourgognon JM, Patel S, Mucha M, Schiavon E, Skrzypiec AE, Young KW, Shiosaka S, Korostynski M, Piechota M, Przewlocki R, Pawlak R
Neuropsin cleaves EphB2 in the amygdala to control anxiety.
Nature. 2011 May 19;473(7347):372-5. PubMed: 21508957PAPER Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, Gerald CP
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia.
Genes Brain Behav. 2007 Oct;6(7):628-39. PubMed: 17212650PAPER Segman RH, Shefi N, Goltser-Dubner T, Friedman N, Kaminski N, Shalev AY
Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors.
Mol Psychiatry. 2005 May;10(5):500-13, 425. PubMed: 15685253Current Filters
No filters selected